Susan K. Parsons, MD, MRP

Associate Director, Research Collaborations; Professor of Medicine
Tufts CTSI; Tufts Medical Center

Dr. Parsons is a Professor of Medicine and Pediatrics at Tufts University School of Medicine and Founding Director of the Reid R. Sacco Adolescent and Young Adult Program for Cancer and Hereditary Blood Disorders at Tufts Medical Center. Her research program is dedicated to advancing the development and application of health-related quality of life (HRQL) assessment of children with serious illness and their parent caregivers. In addition to descriptive research on trajectories of HRQL, the multidisciplinary team of researchers is committed to the design and testing of interventions to support caregivers in their pivotal role. One of the recent examples of this includes the NCI-funded integrated eHealth program, HSCT-CHESS™, which yielded salutary effects on parental emotional functioning for sustained users. Separately, Parsons and her colleagues address the fiscal impact of critical and chronic illness in studies of total cost of care, cost effectiveness, and more globally, value of intervention. Dr. Parsons has a graduate degree in health economics and planning from Cornell University and a medical degree from Columbia University’s College of Physicians and Surgeons. She completed her pediatrics residency and chief residency at Boston Children’s Hospital (BCH) and a fellowship in pediatric hematology/oncology at BCH/Dana-Farber Cancer Institute. Since 2007, she has served as a member of the American Society of Blood and Marrow Transplant expert panel on the role of HSCT in the treatment of acute lymphoblastic leukemia in children and adults, and from 2009-2013, served a co-chair of the Health Policy and Psychosocial Working Committee of the Center for International Blood and Marrow Transplant Research. Previously, she served on the Economic Task Force for the Children’s Oncology Group, as member of the Health Services Committee of the American Society of Clinical Oncology, and as a member of the National Cancer Legislation Advisory Committee for which she chaired the HRQL and Quality of Care round tables.